CRISPR Successfully Treats Muscular Dystrophy in Adult Mammals For the First Time

Researchers treated Duchenne muscular dystrophy using the new gene editing breakthrough, CRISPR. It will be some time before human treatment develops, but clinical trials are moving forward.

January 6, 2016
Subscribe
Like us on Facebook